Grantham, Mayo, Van Otterloo & Co (GMO)
GEHC icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s GE HealthCare GEHC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Buy
400,108
+20,673
+5% +$1.36M 0.06% 154
2026
Q1 		$27M Buy
379,435
+39,721
+12% +$3.13M 0.07% 143
2025
Q4 		$27.9M Buy
339,714
+31,681
+10% +$2.47M 0.07% 126
2025
Q3 		$23.1M Sell
308,033
-34,592
-10% -$2.58M 0.07% 155
2025
Q2 		$25.4M Sell
342,625
-133,876
-28% -$9.32M 0.08% 146
2025
Q1 		$38.5M Buy
476,501
+24,894
+6% +$2.14M 0.12% 111
2024
Q4 		$35.3M Buy
451,607
+7,386
+2% +$628K 0.11% 116
2024
Q3 		$41.7M Sell
444,221
-36,965
-8% -$3.1M 0.13% 108
2024
Q2 		$37.5M Buy
481,186
+180,858
+60% +$14.8M 0.13% 109
2024
Q1 		$27.3M Buy
+300,328
New +$25M 0.1% 148
2023
Q4 		– Sell
-11,849
Closed -$806K – 534
2023
Q3 		$806K Buy
+11,849
New +$862K ﹤0.01% 465

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GEHC Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its GE HealthCare (GEHC) stake by 5.4% in Q2 2026, buying an estimated $1.36M and bringing the position to 400,108 shares worth $25.6M. The position accounts for 0.06% of the portfolio, ranked #154.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GEHC in Q3 2023 and has held it in 11 quarters since. The position peaked at $41.7M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 400,108 shares of GE HealthCare worth $25.6M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 20,673 GE HealthCare shares in Q2 2026, an estimated $1.36M.
  • GE HealthCare made up 0.06% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #154 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GE HealthCare in Q3 2023 and has held it in 11 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s GE HealthCare position peaked at $41.7M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.